Strategic question
As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm fitness for purpose
How Galen Growth helped
From market signal to decision-ready evidence
Galen Growth combined HealthTech Alpha intelligence with structured portfolio risk stratification to assess the relevant markets, ventures, and evidence against the client's decision criteria.
Outcomes
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Pinpointing oncology biomarker scoring algorithms
A global pharmaceutical wanted to identify and shortlist proven ventures that have developed a specific Digital biomarker scoring algorithm capability
Market opportunity optimisation
A global pharma company specialized in women’s health wanted to analyse its priority markets in order to build the future roadmap of innovative solutions for women, starting from telemedicine.
Finding research solutions in Oncology
A large pharmaceutical player sought oncology ventures that could offer advice, patient cohorts, or clinical trials capabilities, in LATAM, Middle East & Asia